ISB News

ISB Takes 1st Place in YarcData Contest

Screengrab from pubcrawl.isbscience.net/ydc

Screengrab from pubcrawl.isbscience.net/ydc

Dr. Brady Bernard, Andrea Eakin, and Dr. Ilya Shmulevich, of The Institute for Systems Biology (ISB), were awarded first prize and will split $70,000 for their winning entry researching more than 25 different types of cancers and thousands of patients to gain insight into the biological networks that are disrupted or altered within a given cancer type and to identify potentially potent approved drugs that could be repurposed for the given cancer.

The winning solution combined unstructured data from medical articles with structured data from genomic and proteomic databases. Using YarcData’s uRiKA graph analytics appliance, this team combined these disparate data sources into a powerful tool for scientific discovery enabling researchers to formulate a theory, quickly test it against all available data, and interactively refine the hypothesis.

“In the amount of time it takes to explore one hypothesis, we can now explore thousands of hypotheses, massively improving our success rate,” said Dr. Ilya Shmulevich, Professor, Institute for Systems Biology. “Our queries needed to cross multiple genes and diverse cancer datasets, producing results in seconds to queries several pages long on graphs of billions of edges. Before YarcData, it has not been possible to perform this type of large scale analysis and identify complex multivariate relationships in heterogeneous data.”

Read the full press release here.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.